CERS Q4 2022 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$44M+10.5% YoY

Gross Profit

$25M55.7% margin

Operating Income

-$10M-22.6% margin

Net Income

-$14M-30.9% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+11.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$218M

Total Liabilities

$150M

Stockholders' Equity

$68M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$40M	+10.5%
Gross Profit	$25M	$20M	+20.3%
Operating Income	-$10M	-$7M	-42.9%
Net Income	-$14M	-$9M	-49.4%

Revenue Segments

Government Contract

$7M100%

Geographic Segments

North America

$30M68%

Europe Middle East And Africa

$13M31%

Other

$430,0001%